CASTLE BIOSCIENCES INC (CSTL)
↓ Download CSV- Sector Services
- Incorporated DE
- Fiscal year ends Dec 31
In fiscal 2025, CASTLE BIOSCIENCES INC reported revenue of $344.23M, up 3.7% from the prior year. The company ran a net loss, with a net margin of -7.0%. It held $578.56M in total assets against $107.68M in total liabilities.
Key ratios (FY2025)
-12.4%
Operating margin
-7.0%
Net margin
-5.1%
Return on equity
+3.7%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $344.23M | $332.07M | $219.79M | $137.04M | $94.08M | $62.65M | $51.87M | $22.79M | — |
| Cost of Revenue | $71.03M | $60.20M | $44.98M | $32.01M | $15.82M | — | — | — | — |
| Gross Profit | — | — | — | — | — | $52.96M | $44.55M | $17.49M | — |
| Operating Income | -$42.81M | $8.67M | -$67.98M | -$72.86M | -$40.08M | -$6.54M | $7.33M | -$3.84M | — |
| Net Income | -$24.16M | $18.25M | -$57.47M | -$67.14M | -$31.29M | -$10.28M | $5.28M | -$6.37M | — |
| EPS (Diluted) | $-0.83 | $0.62 | $-2.14 | $-2.58 | $-1.24 | $-0.54 | $-0.21 | $-5.33 | — |
| Total Assets | $578.56M | $531.24M | $453.34M | $447.33M | $462.57M | $439.33M | $119.75M | $22.41M | — |
| Total Liabilities | $107.68M | $75.40M | $62.07M | $48.18M | $50.83M | $23.64M | $34.63M | $32.48M | — |
| Shareholders' Equity | $470.87M | $455.83M | $391.27M | $399.15M | $411.74M | $415.69M | $85.11M | -$56.57M | -$50.31M |
| Cash & Equivalents | $116.73M | $119.71M | $98.84M | $122.95M | $329.63M | $409.85M | $98.84M | $4.48M | — |
| Operating Cash Flow | $64.35M | $64.87M | -$5.63M | -$41.66M | -$18.98M | $9.87M | $7.01M | -$12.29M | — |
| Capital Expenditures | $36.02M | $28.33M | $13.62M | $5.63M | $3.48M | $4.75M | $937.0K | $277.0K | — |
| Shares Outstanding | 29.69M | 28.48M | 27.41M | 26.55M | 25.38M | 24.81M | 17.13M | 1.92M | — |
| Dividends Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |